TXG financials
10x Genomics (TXG) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TXG income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $642.82M | $443.88M | -$110.89M | -$43.54M | -0.35 |
| 2024 | $610.78M | $414.48M | -$194.56M | -$182.63M | -1.52 |
| 2023 | $618.73M | $409.31M | -$265.33M | -$255.10M | -2.18 |
| 2022 | $516.41M | $396.02M | -$167.94M | -$166.00M | -1.46 |
| 2021 | $490.49M | $416.40M | -$52.91M | -$58.22M | -0.53 |
| 2020 | $298.85M | $240.38M | -$85.32M | -$542.73M | -5.37 |
- TXG revenue was $642.82M in fiscal 2025, net income -$43.54M.
Updated 2026-11-02 17:56 UTC